CHIARLE, Roberto

CHIARLE, Roberto  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 28 (tempo di esecuzione: 0.029 secondi).
Titolo Data di pubblicazione Autore(i) File
ALK inhibitors and vaccination against anaplastic lymphoma kinase (ALK) induce potent anti-tumor activity improving survival in non small cell lung carcinoma (NSCLC) 2012 C. Voena; M. Menotti; C. Mastini; F. Di Giacomo; D.L. Longo; C. Martinengo; S. Aime; F. Cavallo; G. Inghirami; R. Chiarle
CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation 2005 Boccalatte F; Piva R; Manazza A; Palestro G; Chiarle R; Inghirami G
Conditional expression of activated met in differentiated skeletal muscle induces atrophy 2006 CREPALDI T.; BERSANI F.; SCUOPPO C.; ACCORNERO P.; PRUNOTTO C.; TAULLI R.; FORNI P.; LEO C.; CHIARLE R.; GRIFFITHS J.; GLASS D.; PONZETTO C.
Constitutively active STAT3 triggers the development of autoimmune myocarditis 2009 Camporeale A; Marino F; Brero A; Chiarle R; Jensen O; Levi R; Poli V
Constitutively active Stat3 triggers the development of autoimmune myocarditis 2009 Camporeale A; Marino F; Brero A; Chiarle R; Jensen O; Levi R; Poli V
Dissection of critical pathways instrumental for Anaplastic Lymphoma Kinase transformation 2007 Piva R; E Pellegrino; V Grosso; AD Manazza; F Boccalatte; V Poli; A Neri; R Chiarle; G Inghirami
Dissection of critical pathways instrumental to the Anaplastic Lymphoma Kinase oncogenic activity 2007 Piva R; Pellegrino E; Chiarle R; Manazza AD; Boccalatte F; Neri A; Levy DE; Inghirami G
DNA vaccination with alpha-enolase effectively prolongs survival in amouse model of human pancreatic cancer. 2011 Paola Cappello; Simona Rolla; Roberta Curto; Helen Carnevale; Roberto Chiarle; Federica Cavallo; Mirella Giovarelli; Francesco Novelli
Efficacy of DNA vaccination against Anaplastic Lymphoma Kinase (ALK) in Non Small Cell Lunger carcinoma (NSCLC) 2011 C. Voena; C. Mastini; M. Menotti; F. Di Giacomo; D.L. Longo; C. Martinengo; S. Aime; G. Inghirami; R. Chiarle
Espressione delle Heat Shock Proteins nella nefropatia diabetica sperimentale 2008 Pinach S; Barutta F; Forbes J; Chiarle R; Giunti S; Arnstein M; Miceli I; Cavallo Perin P; Camussi G; Cooper ME; Gruden G
Expression of angiogenesis-related biomarkers in thymic epithelial tumors (TET). 2010 Marino M; Lattanzio R; Lauriola L; Martucci R; Sioletic S; Gallo E; Palmieri G; Evoli A; Granone P; Palestro G; Chiarle R; Barreca A; Pich A; Remotti D; Pisa R; Martelli M; Truini M; Ascani S; Ruco L; Rendina EA; Tunesi G; Antimi M; Lalle M; Carlini S; Facciolo F; Piantelli M.
Heat shock protein expression in early diabetic nephropathy 2007 Barutta F; Pinach S; Forbes J; Chiarle R; Giunti S; Arnstein M; Cavallo Perin P; Camussi G; Cooper ME; Gruden G.
Identification of genomic and proteomic signatures in lymphomas by inducible shRNA 2005 R Piva; E Pellegrino; M Mattioli; C Voena; C Conte; F Boccalatte; C Ambrogio; A Manazza; A Neri; R Chiarle; G Inghirami
In T lymphocytes, ablation of STAT3 expression reinstates STAT1-dependent apoptosis by both IFNg and IL-6 2006 Regis G; Icardi L; Conti L; Chiarle R; Bernabei P; Poli V; Novelli F.
In the absence of Insulin-like Growth Factor (IGF)-1 signaling, Interferon-gamma (IFN-g) inhibits the growth of human malignant T cells 2006 Conti L; Longo A; Regis G; Giovarelli M; Chiarle R; Novelli F.
Molecola perturbation of IFNγR2 internalization reinstates T cell sensitività to the IFNγ/STAT1 signaling pathway in vitro and in vivo. 5th 2007 Boselli D; Ragimbeau J; Orlando L; Cappello P; Bernabei P; Ambrogio C; Chiarle R; Pellegrini S; Giovarelli M; Novelli F.
p53 overexpression and thymoma prognosis 1996 PICH A; CHIARLE R; CHIUSA L; MOTTA M; PALESTRO G
p53 overexpression, DNA ploidy and cell proliferative activity are prognostic factors in stage I-II thymomas 1995 PICH A; CHIARLE R; CHIUSA L; PONTI R; GEUNA M; PALESTRO G
Parametri biologici di malignità nei linfomi di piccole cellule CD5 positivi 1998 PALESTRO G; PONTI R; CHIUSA L; CHIARLE R; GEUNA M; NOVERO D; PAGANO M; PICH A
Prognostic value of AgNORs in tumour pathology 1996 PICH A; CHIUSA L; CHIARLE R; MARGARIA E